147 related articles for article (PubMed ID: 23572424)
1. Multiple gene polymorphisms can improve prediction of nonvertebral fracture in postmenopausal women.
Lee SH; Lee SW; Ahn SH; Kim T; Lim KH; Kim BJ; Cho EH; Kim SW; Kim TH; Kim GS; Kim SY; Koh JM; Kang C
J Bone Miner Res; 2013 Oct; 28(10):2156-64. PubMed ID: 23572424
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Bone Mineral Density and Fragility Fracture by Genetic Profiling.
Ho-Le TP; Center JR; Eisman JA; Nguyen HT; Nguyen TV
J Bone Miner Res; 2017 Feb; 32(2):285-293. PubMed ID: 27649491
[TBL] [Abstract][Full Text] [Related]
4. Common and rare variants in the exons and regulatory regions of osteoporosis-related genes improve osteoporotic fracture risk prediction.
Lee SH; Kang MI; Ahn SH; Lim KH; Lee GE; Shin ES; Lee JE; Kim BJ; Cho EH; Kim SW; Kim TH; Kim HJ; Yoon KH; Lee WC; Kim GS; Koh JM; Kim SY
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2400-11. PubMed ID: 25119311
[TBL] [Abstract][Full Text] [Related]
5. HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia.
Hwang JY; Lee SH; Kim GS; Koh JM; Go MJ; Kim YJ; Kim HC; Kim TH; Hong JM; Park EK; Lee JY; Kim SY
Bone; 2009 Dec; 45(6):1098-103. PubMed ID: 19651257
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
7. Enhanced osteoporotic fracture prediction in postmenopausal women using Bayesian optimization of machine learning models with genetic risk score.
Wu Q; Dai J
J Bone Miner Res; 2024 May; 39(4):462-472. PubMed ID: 38477741
[TBL] [Abstract][Full Text] [Related]
8. Genetic risk factors identified in populations of European descent do not improve the prediction of osteoporotic fracture and bone mineral density in Chinese populations.
Li YM; Peng C; Zhang JG; Zhu W; Xu C; Lin Y; Fu XY; Tian Q; Zhang L; Xiang Y; Sheng V; Deng HW
Sci Rep; 2019 Apr; 9(1):6086. PubMed ID: 30988369
[TBL] [Abstract][Full Text] [Related]
9. Novel sequence variations in the CER1 gene are strongly associated with low bone mineral density and risk of osteoporotic fracture in postmenopausal women.
Koromila T; Dailiana Z; Samara S; Chassanidis C; Tzavara C; Patrinos GP; Aleporou-Marinou V; Kollia P
Calcif Tissue Int; 2012 Jul; 91(1):15-23. PubMed ID: 22543871
[TBL] [Abstract][Full Text] [Related]
10. Genetic profiling of decreased bone mineral density in an independent sample of Caucasian women.
Xiao X; Roohani D; Wu Q
Osteoporos Int; 2018 Aug; 29(8):1807-1814. PubMed ID: 29713799
[TBL] [Abstract][Full Text] [Related]
11. Association of IL-15 polymorphisms with bone mineral density in postmenopausal Korean women.
Koh JM; Oh B; Ha MH; Cho KW; Lee JY; Park BL; Shin HD; Bae MA; Kim HJ; Hong JM; Kim TH; Shin HI; Lee SH; Kim GS; Kim SY; Park EK
Calcif Tissue Int; 2009 Nov; 85(5):369-78. PubMed ID: 19756346
[TBL] [Abstract][Full Text] [Related]
12. Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.
Riancho JA; Olmos JM; Pineda B; García-Ibarbia C; Pérez-Núñez MI; Nan DN; Velasco J; Cano A; García-Pérez MA; Zarrabeitia MT; González-Macías J
Eur J Endocrinol; 2011 Jan; 164(1):123-31. PubMed ID: 20926594
[TBL] [Abstract][Full Text] [Related]
13. Identification of osteopenic women at high risk of fracture: the OFELY study.
Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
[TBL] [Abstract][Full Text] [Related]
14. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women.
Koh JM; Oh B; Lee JY; Lee JK; Kimm K; Park BL; Shin HD; Lee IK; Kim HJ; Hong JM; Kim TH; Kim GS; Kim SY; Park EK
J Bone Miner Res; 2007 Nov; 22(11):1752-8. PubMed ID: 17620055
[TBL] [Abstract][Full Text] [Related]
15. The role of vitamin D receptor gene polymorphisms in the bone mineral density of Greek postmenopausal women with low calcium intake.
Stathopoulou MG; Dedoussis GV; Trovas G; Theodoraki EV; Katsalira A; Dontas IA; Hammond N; Deloukas P; Lyritis GP
J Nutr Biochem; 2011 Aug; 22(8):752-7. PubMed ID: 21115334
[TBL] [Abstract][Full Text] [Related]
16. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
17. Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk.
Frediani B; Acciai C; Falsetti P; Baldi F; Filippou G; Siagkri C; Spreafico A; Galeazzi M; Marcolongo R
Calcif Tissue Int; 2006 Oct; 79(4):223-9. PubMed ID: 16969597
[TBL] [Abstract][Full Text] [Related]
18. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Watts NB; Geusens P; Barton IP; Felsenberg D
J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
[TBL] [Abstract][Full Text] [Related]
19. Comparing bone mineral density in postmenopausal women with and without vertebral fracture and its value in recognizing high-risk individuals.
Heidari B; Hoshmand S; Hajian K; Heidari P
East Mediterr Health J; 2010 Aug; 16(8):868-73. PubMed ID: 21469569
[TBL] [Abstract][Full Text] [Related]
20. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
